NewEdge Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Sell |
967
-49
| -5% | -$5.2K | ﹤0.01% | 2415 |
|
|
2025
Q1 | $126K | Sell |
1,016
-21
| -2% | -$2.61K | ﹤0.01% | 2220 |
|
|
2024
Q4 | $128K | Sell |
1,037
-230
| -18% | -$28.3K | ﹤0.01% | 2211 |
|
|
2024
Q3 | $141K | Sell |
1,267
-70
| -5% | -$7.8K | ﹤0.01% | 2087 |
|
|
2024
Q2 | $143K | Sell |
1,337
-194
| -13% | -$20.7K | ﹤0.01% | 2013 |
|
|
2024
Q1 | $184K | Buy |
1,531
+392
| +34% | +$47.2K | ﹤0.01% | 1868 |
|
|
2023
Q4 | $140K | Sell |
1,139
-63
| -5% | -$7.75K | ﹤0.01% | 1828 |
|
|
2023
Q3 | $156K | Sell |
1,202
-77
| -6% | -$9.97K | ﹤0.01% | 1703 |
|
|
2023
Q2 | $159K | Buy |
1,279
+144
| +13% | +$17.9K | ﹤0.01% | 1710 |
|
|
2023
Q1 | $166K | Sell |
1,135
-273
| -19% | -$40K | ﹤0.01% | 1601 |
|
|
2022
Q4 | $6.59K | Buy |
+1,408
| New | +$6.59K | ﹤0.01% | 2502 |
|
|
2022
Q1 | – | Sell |
-3,128
| Closed | -$399K | – | 1388 |
|
|
2021
Q4 | $399K | Sell |
3,128
-167
| -5% | -$21.3K | 0.01% | 1185 |
|
|
2021
Q3 | $429K | Buy |
3,295
+1,664
| +102% | +$217K | 0.01% | 790 |
|
|
2021
Q2 | $290K | Buy |
+1,631
| New | +$290K | 0.01% | 919 |
|
|
2017
Q3 | – | Sell |
-26
| Closed | -$3.98K | – | 748 |
|
|
2017
Q2 | $3.98K | Buy |
+26
| New | +$3.98K | ﹤0.01% | 1184 |
|